Evidence map›Paper›PMID 42238453›Full record

ArticlemedRxiv : the preprint server for health sciences2026

The Burden and Genomic Characterization of

Mwelwa Chibuye, Vanessa C Harris, Jaime Brizuela, Samuel Bosomprah, Michelo Simuyandi, Kapambwe Mwape, Suwilanji Silwamba, Fraser Liswaniso, Kennedy Chibesa, Sam Miti and 6 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Mwelwa ChibuyeDepartment of Global Health, Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.
Vanessa C HarrisDepartment of Global Health, Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.
Jaime BrizuelaDepartment of Global Health, Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.
Samuel BosomprahResearch Division, Enterics and Vaccine Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Michelo SimuyandiResearch Division, Enterics and Vaccine Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Kapambwe MwapeResearch Division, Enterics and Vaccine Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Suwilanji SilwambaResearch Division, Enterics and Vaccine Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Fraser LiswanisoResearch Division, Enterics and Vaccine Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Kennedy ChibesaResearch Division, Enterics and Vaccine Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Sam MitiResearch Division, Enterics and Vaccine Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Gonçalo PiedadeDepartment of Global Health, Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.
Charlie C LuchenDepartment of Global Health, Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.
Caroline C ChisengaResearch Division, Enterics and Vaccine Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Daniel R MendeDepartment of Global Health, Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.
Constance SchultszDepartment of Global Health, Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.
Roma ChilengiResearch Division, Enterics and Vaccine Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Funding

Enterovirus interference with rotavirus vaccine replication and immunityR01AI173360 · NIAID · WASHINGTON UNIVERSITY · PI Megan T Baldridge, Vanessa Catherine HARRIS · 2023 to 2026
$2.9M
NIAID NIH HHS R01 AI173360Wellcome Trust
6 · The paper itself

Abstract

Background: Methods: Between 15 September 2020 and 30 November 2021, a prospective cohort study of 1,400 children under five was enrolled during a community census in a peri-urban setting and passively followed for 9.5 months for MSD. During enrollment, socio-demographic data were collected using electronic questionnaires, while clinical data were collected through the DHIS platform. The main outcome, Results: There were 230 first episodes of Interpretation: We report a high burden of Funding: The EDCTP2 program, supported by the European Union, the Faculty for the Future Foundation (FFTF), the Netherlands Organization for Health Research and Development (ZonMw), and Health-Holland AMR-Global, Gloria, and Track-AMR.

Indexed as

antimicrobial resistance (AMR)LMICsShigella diarrheawhole-genome sequencing (WGS)

Identifiers

PMID42238453
PMCPMC13228785

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.